1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and FirmonertinibNon-Small Cell Lung Cancer With EGFR MutationRecruitingPhase 22024-12-12NCT06668103